Inflammatory Biomarkers in Acute Coronary Syndromes
Authors:
- 14 February 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 113 (6) , e72-5
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenNew England Journal of Medicine, 2004
- Overexpression of IL-18 Decreases Intimal Collagen Content and Promotes a Vulnerable Plaque Phenotype in Apolipoprotein-E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Inflammatory Cytokines and Postmyocardial Infarction RemodelingCirculation Research, 2004
- Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial InfarctionCirculation, 2003
- Monocyte Chemoattractant Protein-1 Concentration in Coronary Sinus Blood and Severity of Coronary DiseaseCirculation, 2003
- Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary SyndromesCirculation, 2003
- Inflammation in atherosclerosisNature, 2002
- Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable AnginaCirculation, 2002
- Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery DiseaseJAMA, 2001
- Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6European Heart Journal, 2000